2VT-33982-49611 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-05-15
Dose 1 — Pfizer-BioNTech
2021-06-05
Dose 2 — Pfizer-BioNTech
2021-12-10
Registered in v-safe
2021-12-11
Health check-in — 6 months, dose 2, dependent
Feeling: Good

Adult check-in
2022-01-07
Dose 3 — Pfizer-BioNTech
2022-01-08
Health check-in — days 1–6 daily, dose 3, dependent
Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school

Adult check-in
2022-01-09
Health check-in — days 1–6 daily, dose 3, dependent
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2022-01-10
Health check-in — days 1–6 daily, dose 3, dependent
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2022-01-11
Health check-in — days 1–6 daily, dose 3, dependent
Feeling: Good · Headache

Adult check-in
2022-01-23
Health check-in — day 14, dose 3, dependent
Feeling: Good

Adult check-in
2022-01-30
Health check-in — day 21, dose 3, dependent
Feeling: Good

Adult check-in
2022-01-30
Health check-in — day 42, dose 3, dependent
Feeling: Good

Adult check-in
2022-02-11
Health check-in — day 35, dose 3, dependent
Feeling: Good

Adult check-in
2022-04-10
Health check-in — 3 months, dose 3, dependent
Feeling: Good

Adult check-in
2022-07-09
Health check-in — 6 months, dose 3, dependent
Feeling: Good

Adult check-in
2023-01-02
Dose 4 — Pfizer-BioNTech
2023-01-08
Health check-in — days 1–6 daily, dose 4, dependent
Feeling: Fair · Headache, Nausea · Be unable to do your normal daily activities

Adult check-in
2023-01-08
Survey response — 12 months, dose 3, dependent
MedDRA: Apathy, Confusional state, Disturbance in attention — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

MedDRA releases: 2024-11
2023-01-08
Report sent to call center — 12 months, dose 3, dependent
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · 1 call case(s)
2023-01-09
Call 1 — Left Voicemail
2023-01-17
Health check-in — day 14, dose 4, dependent
Feeling: Good

Adult check-in
2023-01-24
Health check-in — day 21, dose 4, dependent
Feeling: Good

Adult check-in
2023-01-31
Health check-in — day 28, dose 4, dependent
Feeling: Good

Adult check-in
2023-02-13
Health check-in — day 42, dose 4, dependent
Feeling: Good

Adult check-in
2023-04-06
Health check-in — 3 months, dose 4, dependent
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-05-15	Pfizer-BioNTech	No
2	2021-06-05	Pfizer-BioNTech	No
3	2022-01-07	Pfizer-BioNTech	No
4	2023-01-02	Pfizer-BioNTech	No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Apathy	·	·	✓
SD	Confusional state	·	·	✓
SD	Disturbance in attention	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release